Rothschild Investment LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
403
+3
| +0.8% | +$1.58K | 0.01% | 501 |
|
|
2025
Q1 | $254K | Sell |
400
-55
| -12% | -$34.9K | 0.02% | 450 |
|
|
2024
Q4 | $324K | Sell |
455
-85
| -16% | -$60.5K | 0.02% | 410 |
|
|
2024
Q3 | $568K | Sell |
540
-56
| -9% | -$58.9K | 0.04% | 322 |
|
|
2024
Q2 | $626K | Buy |
596
+83
| +16% | +$87.2K | 0.04% | 298 |
|
|
2024
Q1 | $494K | Buy |
513
+12
| +2% | +$11.6K | 0.04% | 327 |
|
|
2023
Q4 | $440K | Buy |
501
+27
| +6% | +$23.7K | 0.04% | 297 |
|
|
2023
Q3 | $390K | Buy |
474
+32
| +7% | +$26.3K | 0.03% | 336 |
|
|
2023
Q2 | $318K | Buy |
442
+24
| +6% | +$17.3K | 0.03% | 373 |
|
|
2023
Q1 | $343K | Sell |
418
-196
| -32% | -$161K | 0.03% | 350 |
|
|
2022
Q4 | $443K | Sell |
614
-56
| -8% | -$40.4K | 0.04% | 305 |
|
|
2022
Q3 | $462K | Hold |
670
| – | – | 0.05% | 290 |
|
|
2022
Q2 | $396K | Hold |
670
| – | – | 0.04% | 331 |
|
|
2022
Q1 | $468K | Hold |
670
| – | – | 0.04% | 336 |
|
|
2021
Q4 | $423K | Hold |
670
| – | – | 0.03% | 350 |
|
|
2021
Q3 | $405K | Hold |
670
| – | – | 0.03% | 345 |
|
|
2021
Q2 | $374K | Sell |
670
-250
| -27% | -$140K | 0.03% | 367 |
|
|
2021
Q1 | $435K | Buy |
920
+184
| +25% | +$87K | 0.04% | 339 |
|
|
2020
Q4 | $356K | Hold |
736
| – | – | 0.03% | 335 |
|
|
2020
Q3 | $412K | Sell |
736
-75
| -9% | -$42K | 0.04% | 287 |
|
|
2020
Q2 | $506K | Hold |
811
| – | – | 0.06% | 246 |
|
|
2020
Q1 | $396K | Buy |
811
+216
| +36% | +$105K | 0.05% | 271 |
|
|
2019
Q4 | $223K | Buy |
+595
| New | +$223K | 0.02% | 406 |
|